Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease
This study aims to investigate the expression level of SLC25A48, a mitochondrial choline transporter, in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease, and to analyze its correlation with inflammatory markers and choline metabolic byproducts.
pre-COPD or COPD stages I-IV as per the 2023 GOLD guidelines (case group) [+1]
diagnosed with neuromuscular diseases [+4]